Daniel C. Martin

Chief Commercial Officer, Deciphera Pharmaceuticals, Inc.

Companies

Deciphera Pharmaceuticals, Inc.Chief Commercial Officer Sep 20, 2018 to Jun 11, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 11, 2024U 31,330 shares of Deciphera Pharmaceuticals, Inc.²
Jun 11, 2024Returned to company 43,951 shares of Deciphera Pharmaceuticals, Inc.²
Jun 11, 2024Granted 20,163 shares of Deciphera Pharmaceuticals, Inc.²
Feb 16, 2024Sold 2,267 shares at $15.62 of Deciphera Pharmaceuticals, Inc.³
Feb 15, 2024Granted 9,725 shares of Deciphera Pharmaceuticals, Inc.³
Jan 16, 2024Sold 1,624 shares at $14.47 of Deciphera Pharmaceuticals, Inc.⁴
Dec 13, 2023Sold 1,727 shares at $15.37 of Deciphera Pharmaceuticals, Inc.⁵
Dec 12, 2023Granted 5,576 shares of Deciphera Pharmaceuticals, Inc.⁵
Nov 30, 2023Sold 17,801 shares at $12.57 of Deciphera Pharmaceuticals, Inc.⁶
Oct 30, 2023Sold 1,407 shares at $12.02 of Deciphera Pharmaceuticals, Inc.⁷
Oct 28, 2023Granted 5,576 shares of Deciphera Pharmaceuticals, Inc.⁷
Jun 16, 2023Sold 1,238 shares at $14.40 of Deciphera Pharmaceuticals, Inc.⁸
Feb 16, 2023Sold 1,159 shares at $15.10 of Deciphera Pharmaceuticals, Inc.⁹
Feb 15, 2023Granted 11,151 shares of Deciphera Pharmaceuticals, Inc.⁹
Jan 17, 2023Sold 1,603 shares at $21.24 of Deciphera Pharmaceuticals, Inc.¹⁰
Jun 16, 2022Sold 1,311 shares at $10.75 of Deciphera Pharmaceuticals, Inc.¹¹
Feb 16, 2022Sold 1,146 shares at $9.05 of Deciphera Pharmaceuticals, Inc.¹²
Jan 18, 2022Granted 13,667 shares of Deciphera Pharmaceuticals, Inc.¹³
Dec 15, 2021Granted 8,300 shares of Deciphera Pharmaceuticals, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.